NIPH Clinical Trials Search

Basic Information

Recruitment status
Health condition(s) or Problem(s) studied	Type 2 Diabetes
Date of first enrollment	19/10/2005
Target sample size	264
Countries of recruitment
Study type	Interventional
Intervention(s)	investigational material(s) Generic name etc : Vildagliptin INN of investigational material : Therapeutic category code : 396 Antidiabetic agents Dosage and Administration for Investigational material : Oral

Outcome(s)

Primary Outcome	Change from baseline in HbA1c at 12 weeks
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	>= 20age old
Age maximum	<= 75age old
Gender	Both
Include criteria	Inclusion criteria - Male or female aged 20 to 75 years old - Diagnosis as Type 2 Diabetes - Patients who have been placed on dietary therapy / exercise therapy, without achievement of glycemic control - Outpatients Exclusion criteria - - Type 1 diabetes mellitus, diabetes that is a result of pancreatic injury, or secondary forms of diabetes - Significant heart diseases - Significant diabetic complications Other protocol-defined exclusion criteria may apply.
Exclude criteria